annual FCF:
$172.34M+$27.01M(+18.58%)Summary
- As of today (July 1, 2025), AMPH annual free cash flow is $172.34 million, with the most recent change of +$27.01 million (+18.58%) on December 31, 2024.
- During the last 3 years, AMPH annual FCF has risen by +$101.81 million (+144.33%).
- AMPH annual FCF is now at all-time high.
Performance
AMPH Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$24.38M+$7.77M(+46.75%)Summary
- As of today (July 1, 2025), AMPH quarterly free cash flow is $24.38 million, with the most recent change of +$7.77 million (+46.75%) on March 31, 2025.
- Over the past year, AMPH quarterly FCF has dropped by -$22.12 million (-47.57%).
- AMPH quarterly FCF is now -61.34% below its all-time high of $63.06 million, reached on June 30, 2024.
Performance
AMPH quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$150.23M-$22.12M(-12.83%)Summary
- As of today (July 1, 2025), AMPH TTM free cash flow is $150.23 million, with the most recent change of -$22.12 million (-12.83%) on March 31, 2025.
- Over the past year, AMPH TTM FCF has dropped by -$10.70 million (-6.65%).
- AMPH TTM FCF is now -15.66% below its all-time high of $178.13 million, reached on June 30, 2024.
Performance
AMPH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AMPH Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.6% | -47.6% | -6.7% |
| 3 y3 years | +144.3% | -45.4% | +50.3% |
| 5 y5 years | +10000.0% | +473.4% | +1495.1% |
AMPH Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.6% | -61.3% | +874.7% | -15.7% | +192.1% |
| 5 y | 5-year | at high | >+9999.0% | -61.3% | +624.3% | -15.7% | +1495.1% |
| alltime | all time | at high | +740.8% | -61.3% | +217.9% | -15.7% | +749.1% |
AMPH Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.38M(+46.8%) | $150.23M(-12.8%) |
| Dec 2024 | $172.34M(+18.6%) | $16.61M(-64.0%) | $172.34M(+1.3%) |
| Sep 2024 | - | $46.17M(-26.8%) | $170.15M(-4.5%) |
| Jun 2024 | - | $63.06M(+35.6%) | $178.13M(+10.7%) |
| Mar 2024 | - | $46.50M(+222.4%) | $160.93M(+10.7%) |
| Dec 2023 | $145.34M(+123.1%) | $14.42M(-73.4%) | $145.34M(+3.9%) |
| Sep 2023 | - | $54.14M(+18.0%) | $139.83M(+39.2%) |
| Jun 2023 | - | $45.87M(+48.4%) | $100.44M(+95.3%) |
| Mar 2023 | - | $30.91M(+246.6%) | $51.43M(-21.1%) |
| Dec 2022 | $65.15M(-7.6%) | $8.92M(-39.6%) | $65.15M(-27.4%) |
| Sep 2022 | - | $14.75M(-568.8%) | $89.79M(+27.6%) |
| Jun 2022 | - | -$3.15M(-107.1%) | $70.39M(-29.6%) |
| Mar 2022 | - | $44.63M(+33.0%) | $99.96M(+41.7%) |
| Dec 2021 | $70.54M(+201.3%) | $33.56M(-821.8%) | $70.54M(+58.4%) |
| Sep 2021 | - | -$4.65M(-117.6%) | $44.54M(-14.9%) |
| Jun 2021 | - | $26.42M(+73.7%) | $52.37M(+16.0%) |
| Mar 2021 | - | $15.21M(+101.0%) | $45.15M(+92.8%) |
| Dec 2020 | $23.41M(>+9900.0%) | $7.56M(+138.2%) | $23.41M(+78.9%) |
| Sep 2020 | - | $3.18M(-83.5%) | $13.09M(-221.6%) |
| Jun 2020 | - | $19.20M(-394.1%) | -$10.77M(-188.4%) |
| Mar 2020 | - | -$6.53M(+136.7%) | $12.18M(+5785.5%) |
| Dec 2019 | $207.00K(-102.4%) | -$2.76M(-86.7%) | $207.00K(-92.9%) |
| Sep 2019 | - | -$20.68M(-149.1%) | $2.90M(-89.1%) |
| Jun 2019 | - | $42.15M(-327.8%) | $26.73M(-215.5%) |
| Mar 2019 | - | -$18.50M(>+9900.0%) | -$23.14M(+168.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$8.62M(-309.7%) | -$65.00K(-102.1%) | -$8.62M(-3.2%) |
| Sep 2018 | - | $3.15M(-140.8%) | -$8.90M(-57.6%) |
| Jun 2018 | - | -$7.72M(+93.9%) | -$20.99M(+39.9%) |
| Mar 2018 | - | -$3.98M(+1027.5%) | -$15.00M(-465.0%) |
| Dec 2017 | $4.11M(-76.1%) | -$353.00K(-96.1%) | $4.11M(-68.7%) |
| Sep 2017 | - | -$8.94M(+417.7%) | $13.13M(-21.2%) |
| Jun 2017 | - | -$1.73M(-111.4%) | $16.67M(-25.3%) |
| Mar 2017 | - | $15.13M(+74.5%) | $22.32M(+30.0%) |
| Dec 2016 | $17.18M(-423.2%) | $8.67M(-260.4%) | $17.18M(+122.3%) |
| Sep 2016 | - | -$5.40M(-237.6%) | $7.73M(-37.5%) |
| Jun 2016 | - | $3.93M(-60.7%) | $12.37M(+64.8%) |
| Mar 2016 | - | $9.98M(-1376.7%) | $7.51M(-241.2%) |
| Dec 2015 | -$5.32M(-1061.1%) | -$782.00K(+3.0%) | -$5.32M(+413.0%) |
| Sep 2015 | - | -$759.00K(-19.0%) | -$1.04M(-111.3%) |
| Jun 2015 | - | -$937.00K(-67.0%) | $9.13M(+17.4%) |
| Mar 2015 | - | -$2.84M(-181.1%) | $7.78M(+1306.3%) |
| Dec 2014 | $553.00K(-95.7%) | $3.50M(-62.8%) | $553.00K(-67.7%) |
| Sep 2014 | - | $9.41M(-510.2%) | $1.71M(-114.8%) |
| Jun 2014 | - | -$2.29M(-77.2%) | -$11.53M(-251.5%) |
| Mar 2014 | - | -$10.06M(-316.1%) | $7.61M(-40.3%) |
| Dec 2013 | $12.74M(-147.4%) | $4.66M(-221.4%) | $12.74M(+57.6%) |
| Sep 2013 | - | -$3.83M(-122.8%) | $8.08M(-32.2%) |
| Jun 2013 | - | $16.85M(-441.6%) | $11.92M(-341.6%) |
| Mar 2013 | - | -$4.93M | -$4.93M |
| Dec 2012 | -$26.89M(-421.0%) | - | - |
| Dec 2011 | $8.38M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual FCF year-on-year change?
- What is Amphastar Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly FCF year-on-year change?
- What is Amphastar Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM FCF year-on-year change?
What is Amphastar Pharmaceuticals annual free cash flow?
The current annual FCF of AMPH is $172.34M
What is the all time high annual FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual free cash flow is $172.34M
What is Amphastar Pharmaceuticals annual FCF year-on-year change?
Over the past year, AMPH annual free cash flow has changed by +$27.01M (+18.58%)
What is Amphastar Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AMPH is $24.38M
What is the all time high quarterly FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly free cash flow is $63.06M
What is Amphastar Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AMPH quarterly free cash flow has changed by -$22.12M (-47.57%)
What is Amphastar Pharmaceuticals TTM free cash flow?
The current TTM FCF of AMPH is $150.23M
What is the all time high TTM FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM free cash flow is $178.13M
What is Amphastar Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AMPH TTM free cash flow has changed by -$10.70M (-6.65%)